Official Journal of Research Center for Gastroenterology and Liver Diseases
e-ISSN 1735-3408
p-ISSN 1735-143X
Citation data
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
8 resultsUpdated October 15, 2026
1
Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review
Cost Effectiveness and Resource Allocation
December 2026
Jafari M.
Open Access
2
A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran
Cost Effectiveness and Resource Allocation
December 2025
Jafari M.
Open Access
3
Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study
BMJ Open
11 September 2025
Jafari M.
Open Access
4
Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C
Hepatitis Monthly
Aug 2021
Goudarzi Z.
Open Access
5
A cost-utility analysis of different antiviral medicine regimens in patients with chronic hepatitis c virus genotype 1 infection
Iranian Red Crescent Medical Journal
1 November 2016
Alavian S.M.
All Open Access, Green
6
Next steps toward eradication of hepatitis C in the era of direct acting antivirals
Hepatitis Monthly
18 April 2016
Hesamizadeh K.
Open Access
7
New use of an old drug: Chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial)
Canadian Journal of Physiology and Pharmacology
2016
Peymani P.
All Open Access, Green
8
Occult HCV infection: The current state of knowledge
Iranian Red Crescent Medical Journal
29 November 2015
Rezaee-Zavareh M.S.
All Open Access, Green